Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: Results from the Strategies for Management of Antiretroviral Therapy study

Journal of Electrocardiology

Volumn 44, Issue 6, 2011, Pages 779-785

  Soliman, Elsayed Z ^a   Prineas, Ronald J ^a   Roediger, Mollie P ^b   Duprez, Daniel A ^c   Boccara, Franck ^d   Boesecke, Christoph ^e   Stephan, Christoph ^f   Hodder, Sally ^g   Stein, James H ^h   Lundgren, Jens D ⁱ   Neaton, James D ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Saint Antoine University   (France)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁱ International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Cardiovascular disease; ECG; HIV AIDS; SMART study

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIOVASCULAR DISEASE; ECG ABNORMALITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PR INTERVAL; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; QT PROLONGATION; R WAVE; ST SEGMENT; ST SEGMENT ELEVATION; T WAVE;

ADULT; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 80054924053     PISSN: 00220736     EISSN: 15328430     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2010.10.027     Document Type: Article

References (28)

1. Currier J.S., Taylor A., and Boyd F. Coronary heart disease in HIV-infected individuals J Acquir Immune Defic Syndr 33 2003 506
2. Friis-Møller N., Sabin C.A., and Weber R. Combination antiretroviral therapy and the risk of myocardial infarction N Engl J Med 349 2003 1993
3. Friis-Møller N., Reiss P., and Sabin C.A. Class of antiretroviral drugs and the risk of myocardial infarction N Engl J Med 356 2007 1723
4. Triant V.A., Lee H., Hadigan C., and Grinspoon S.K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2007 2506
5. Bozzette S.A., Ake C.F., Tam H.K., Chang S.W., and Louis T.A. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection N Engl J Med 348 2003 702
6. Iloeje U.H., Yuan Y., and L'Italien G. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients HIV Med 6 2005 37
7. Obel N., Thomsen H.F., and Kronborg G. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study Clin Infect Dis 44 2007 1625
8. Currier J.S., Lundgren J.D., and Carr A. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy Circulation l 8 2008 e29
9. Crow R.S., Prineas R.J., Hannan P.J., Grandits G., and Blackburn H. Prognostic associations of Minnesota Code serial electrocardiographic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial Am J Cardiol 80 1997 138
10. Daviglus M.L., Liao Y., and Greenland P. Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric study JAMA 281 1999 530
11. De Bacquer D., Martins Pereira L.S., De Backer G., De Henauw S., and Kornitzer M. The predictive value of electrocardiographic abnormalities for total and cardiovascular disease mortality in men and women Eur Heart J 15 1994 1604
12. Greenland P., Xie X., and Liu K. Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up Am J Cardiol 91 2003 1068
13. Liao Y.L., Liu K.A., and Dyer A. Major and minor electrocardiographic abnormalities and risk of death from coronary heart disease, cardiovascular diseases and all causes in men and women J Am Coll Cardiol 12 1988 1494
14. Sutherland S.E., Gazes P.C., Keil J.E., Gilbert G.E., and Knapp R.G. Electrocardiographic abnormalities and 30-year mortality among white and black men of the Charleston Heart study Circulation 88 1993 2685
15. Carr A., Grund B., Neuhaus J., El-Sadr W.M., and Grandits G. Asymptomatic myocardial ischaemia in HIV-infected adults AIDS 22 2008 257
16. Charbit B., Rosier A., Bollens D., and Boccara Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients Br J Clin Pharmacol 67 2009 76
17. Reinsch N., Buhr C., and Krings P. Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study HIV Clin Trials 10 2009 261
18. The SMART Study Group CD4+ count-guided interruption of antiretroviral therapy N Engl J Med 355 2006 2283
19. SMART Study Group Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy, a randomized trial Ann Int Med 149 2008 289
20. Panel on Clinical Practices for Treatment of HIV Infection Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (Accessed February 2, 2010). http://aidsinfo.nih.gov/contentfiles/ AdultandAdolescentGL.pdf 2009
21. Prineas R.J., Crow R.S., and Blackburn H. The Minnesota Code manual of electrocardiographic findings 1982 John Wright-PSG Littleton, MA
22. Lifson A.R., Belloso W.H., and Carey C. Determination of the underlying cause of death in three multicenter international HIV clinical trials HIV Clin Trials 9 2008 177
23. De-Bacquer D., De-Backer G., and Kornitzer M. Prevalence of ECG findings in large population based samples of men and women Heart 84 2000 625
24. Strogatz D.S., Tyroler H.A., Watkins L.O., and Hames C.G. Electrocardiographic abnormalities and mortality among middle-aged black men and white men of Evans County, Georgia J Chron Dis 40 1987 149
25. De-Bacquer D., Pereira M., De-Backer G., De-Henauw S., and Kornitzer M. Prevalence and correlate of ECG abnormalites in the adult Belgian population J Electrocardiol 28 1995 1
26. Vitelli L.L., Crow R.S., Shahar E., Hutchinson R.G., Rautaharju P.M., and Folsom A.R. Electrocardiographic findings in a healthy biracial population. Atherosclerosis Risk in Communities (ARIC) study investigators Am J Cardiol 81 1998 453
27. Möhlenkamp S., Schmermund A., and Lehmann N. Subclinical coronary atherosclerosis and resting ECG abnormalities in an unselected general population 2008 Atherosclerosis 196 2008 786
28. Lloyd-Jones D.M., Walsh J.A., and Prineas R.J. Association of electrocardiographic abnormalities with coronary artery calcium and carotid artery intima-media thickness in individuals without clinical coronary heart disease (from the Multi-Ethnic Study of Atherosclerosis [MESA]) Am J Cardiol 104 2009 1086